Rapid Nutrition PLC (ALRPD.PA)
EUR 0.01
(-5.08%)
EUR 0.01
(-5.08%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 269.61 Thousand AUD | -87.02% |
| 2022 | 2.07 Million AUD | 1.68% |
| 2021 | 2.04 Million AUD | 103.3% |
| 2020 | 1 Million AUD | 0.0% |
| 2018 | 2.05 Million AUD | -50.4% |
| 2017 | 4.13 Million GBP | 81.93% |
| 2016 | 2.27 Million GBP | -33.58% |
| 2015 | 3.42 Million GBP | -37.5% |
| 2014 | 5.48 Million GBP | 463.73% |
| 2013 | 972.2 Thousand GBP | 864.23% |
| 2012 | 100.82 Thousand AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | 120.95 Thousand AUD | 0.0% |
| 2023 Q4 | 13.85 Thousand AUD | 0.0% |
| 2023 Q1 | 120.95 Thousand AUD | 3.56% |
| 2023 FY | 269.61 Thousand AUD | -87.02% |
| 2023 Q3 | 13.85 Thousand AUD | -88.54% |
| 2022 Q1 | 123.83 Thousand AUD | -78.18% |
| 2022 Q4 | 116.79 Thousand AUD | 0.0% |
| 2022 Q3 | 116.79 Thousand AUD | -5.68% |
| 2022 Q2 | 123.83 Thousand AUD | -0.0% |
| 2022 FY | 2.07 Million AUD | 1.68% |
| 2021 Q1 | 559.72 Thousand AUD | 0.0% |
| 2021 Q3 | 567.53 Thousand AUD | 1.4% |
| 2021 Q4 | 567.53 Thousand AUD | 0.0% |
| 2021 Q2 | 559.72 Thousand AUD | 0.0% |
| 2021 FY | 2.04 Million AUD | 103.3% |
| 2020 FY | 1 Million AUD | 0.0% |
| 2019 Q4 | 507.09 Thousand AUD | 0.0% |
| 2019 Q2 | 773.66 Thousand AUD | 0.0% |
| 2019 Q1 | 773.66 Thousand AUD | 205.98% |
| 2019 Q3 | 507.09 Thousand AUD | -34.46% |
| 2018 Q4 | 252.85 Thousand AUD | -0.0% |
| 2018 Q3 | 252.85 Thousand AUD | 2.33% |
| 2018 FY | 2.05 Million AUD | -50.4% |
| 2018 Q2 | 247.1 Thousand AUD | -34.09% |
| 2018 Q1 | 374.91 Thousand AUD | -60.46% |
| 2017 Q1 | 372.63 Thousand AUD | -48.9% |
| 2017 Q3 | 936.35 Thousand AUD | 143.16% |
| 2017 Q4 | 948.25 Thousand AUD | 1.27% |
| 2017 Q2 | 385.08 Thousand AUD | 3.34% |
| 2017 FY | 4.13 Million GBP | 81.93% |
| 2016 Q1 | 534.19 Thousand AUD | -28.28% |
| 2016 Q3 | 729.2 Thousand AUD | 240.41% |
| 2016 Q4 | 729.2 Thousand AUD | 0.0% |
| 2016 Q2 | 214.21 Thousand AUD | -59.9% |
| 2016 FY | 2.27 Million GBP | -33.58% |
| 2015 FY | 3.42 Million GBP | -37.5% |
| 2015 Q4 | 744.88 Thousand AUD | 0.0% |
| 2015 Q3 | 744.88 Thousand AUD | -50.37% |
| 2015 Q2 | 1.5 Million AUD | 0.0% |
| 2015 Q1 | 1.5 Million AUD | 122.04% |
| 2014 Q3 | 675.95 Thousand AUD | 818.64% |
| 2014 FY | 5.48 Million GBP | 463.73% |
| 2014 Q4 | 675.95 Thousand AUD | 0.0% |
| 2014 Q2 | -94.06 Thousand AUD | 0.0% |
| 2013 Q2 | -240.64 Thousand AUD | 0.0% |
| 2013 FY | 972.2 Thousand GBP | 864.23% |
| 2012 FY | 100.82 Thousand AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AB Science S.A. | 587 Thousand EUR | 54.07% |
| Boiron SA | 358.08 Million EUR | 99.925% |
| Ipsen S.A. | 2.73 Billion EUR | 99.99% |
| Malin Corporation plc | - EUR | -Infinity% |
| Vetoquinol SA | 291.37 Million EUR | 99.907% |